Skip to search formSkip to main contentSkip to account menu

Rocuronium

Known as: 1-(17-(acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Background and objectives: This prospective, double‐blind, randomized, placebo‐controlled study was designed to determine the… 
Highly Cited
2003
Highly Cited
2003
Background and objective: Rocuronium and, to a lesser extent, vecuronium can induce burning sensations associated with withdrawal… 
2003
2003
We evaluated the pretreatment of small-dose of ketamine or normal saline in the reduction of withdrawal movements induced by… 
Highly Cited
2002
Highly Cited
2002
Rapid-sequence induction with cricoid pressure is a standard procedure for inducing anesthesia in patients with a potentially… 
2002
2002
BACKGROUND AND OBJECTIVE The aim was to compare the effects of two different priming doses and priming intervals with the… 
1998
1998
PurposeTo describe the prolonged effect of the intermediate-acting, non-depolarising neuromuscular blocking agents rocuronium and… 
1998
1998
PurposeTo evaluate a rapid and time-saving precurarization technique using rocuronium to prevent succinylcholine-induced myalgia… 
Highly Cited
1996
Highly Cited
1996
Background: Rocuronium (Org 9426) was shown to have the fastest onset of action of all currently available non‐depolarizing… 
1996
1996
We studied 20 infants, 20 children and 20 adults during balanced anaesthesia to compare the neuromuscular blocking effects of…